表紙:医薬品開発業務受託機関(CRO)の市場機会(2020年)
市場調査レポート
商品コード
939694

医薬品開発業務受託機関(CRO)の市場機会(2020年)

2020 Contract Research Organization Market Opportunity Report

出版日: | 発行: Strategic Directions International, Inc. | ページ情報: 英文 92 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=129.43円
医薬品開発業務受託機関(CRO)の市場機会(2020年)
出版日: 2020年04月29日
発行: Strategic Directions International, Inc.
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
担当者のコメント
CROサービスの需要が高まるにつれ、CROが使用する分析機器のサプライヤーの市場機会も成長します。 このレポートはCRO業界の分析機器市場を評価し、8つの技術カテゴリにグループ化された53の技術を調査します。技術、地域、およびアプリケーションごとの需要と成長の予測を提供するレポートです。
  • 全表示
  • 概要
  • 目次
概要

当レポートは医薬品開発業務受託機関(CRO)市場について調査しており、市場の機会や脅威、地域の動向、カテゴリー別の需要分析、主要企業のプロファイル等の情報を提供しています。

当レポート掲載の企業情報

  • Agilent
  • BD Biosciences
  • Beckman Coulter (Danaher)
  • Bio-Rad
  • Bruker
  • GE Healthcare
  • Hamilton
  • Illumina
  • Mettler-Toledo
  • MilliporeSigma
  • Molecular Devices (Danaher)
  • PerkinElmer
  • QIAGEN
  • Roche
  • Sartorius
  • SCIEX (Danaher)
  • 株式会社島津製作所
  • Tecan
  • Thermo Fisher
  • Waters

目次

イントロダクション

市場分析

  • CRO業界の概要
  • 市場機会と脅威
  • 地域動向

市場の需要

  • 全体的な需要
  • ライフサイエンス機器
  • クロマトグラフィー
  • 質量分析
  • ラボの自動化と情報学
  • 実験装置
  • サンプル前処理
  • 分子分光法
  • 材料の特性評価
目次
Product Code: 20-011

Contract research organizations (CROs) are essential partners in the drug development field. As companies in the pharmaceutical and biotechnology industries shift their development pipelines towards more targeted therapies, the cost of development has significantly increased while the patient pool for each drug is smaller. This has resulted in leaner R&D infrastructures and increasing reliance on outsourcing.

CROs provide critical services and expertise for all stages of drug development, from target selection to clinical trial administration, and are important partners in regulatory compliance, validation, and gaining product approval. CROs also provide important resources for technologies that require significant capital investments and technical expertise.

As demand for CRO services increases, the market opportunities for suppliers of analytical instrumentation used by CROs will see significant growth, even in the face of the global COVID-19 pandemic and subsequent recession. The ‘2020 Contract Research Organization Market Opportunity Report’ evaluates the global analytical instrumentation market for the CRO industry, examining 53 techniques grouped into 8 technological categories. The goal of the report is to provide demand and growth projections by technique, region, and application, within the context of the current global health crisis and anticipated economic recession conditions.

Report Overview

  • CRO market background and current opportunities and threats
  • Global trends for CROs by region
  • Market demand and five-year forecasts, segmented by technology, region, function, and application
  • Analysis of 53 technologies within the following eight categories:
    • Life Science Instrumentation
    • Chromatography
    • Mass Spectrometry
    • Lab Automation & Software
    • Lab Equipment
    • Sample Preparation
    • Molecular Spectroscopy
    • Materials Characterization
  • Competitive landscape and market share of vendors in each technology category. Participants include the following:
    • Agilent
    • BD Biosciences
    • Beckman Coulter (Danaher)
    • Bio-Rad
    • Bruker
    • GE Healthcare
    • Hamilton
    • Illumina
    • Mettler-Toledo
    • MilliporeSigma
    • Molecular Devices (Danaher)
    • PerkinElmer
    • QIAGEN
    • Roche
    • Sartorius
    • SCIEX (Danaher)
    • Shimadzu
    • Tecan
    • Thermo Fisher
    • Waters

Table of Contents

Introduction

  • About This Report
  • Executive Summary
  • Scope & Definitions
  • Methodology

Market Insights

  • CRO Industry Overview
  • Market Opportunities & Threats
  • Regional Trends

Market Demand

  • Overall Demand
  • Life Science Instrumentation
  • Chromatography
  • Mass Spectrometry
  • Lab Automation & Informatics
  • Lab Equipment
  • Sample Preparation
  • Molecular Spectroscopy
  • Materials Characterization